Tempus | AI-enabled precision medicine Tempus has built the world’s largest library of clinical molecular data and an operating system to make that data accessible and useful, starting with cancer
Providers - Tempus For clinicians associated with advanced research initiatives, Tempus provides next-generation genomic profiling, biological organoid modeling, image pattern AI recognition, and a range of clinical trial and research collaborations
Home - Tempus Unlimited Tempus Unlimited exists to provide a continuum of community based services that support the efforts of children and adults with disabilities to live as independently as possible in the least restrictive environment
Tempus AI - Wikipedia Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM " [6][7]
Tempus | SoftBank Group Corp. Launched in the United States in 2015, Tempus is now one of the largest sequencers of cancer patients in the world Having built its platform for oncology, it has expanded to neuropsychiatry, cardiology, infectious disease, and radiology